THERE IN NO FDA APPROVAL OF THE COVID INJECTIONS!!!!
THEY LIE!!!! THEY ALWAYS LIE!!!!
THEY DECEIVE THE SHEEPLE WITH LIES AND FOOL THEM EVERY TIME!!!!!
THE FDA EXTENDED THE “EMERGENCY AUTHORIZATION” FOR THE COVID-19 “BOOSTER” INJECTIONS WHILE TELLING THE PUBLIC IT IS AN “APPROVAL”.
THIS IS A PSYCHOLOGICAL WARFARE TACTIC BEING USED TO COVER UP AN EVIL, INSIDIOUS, GENOCIDAL CRIME AGAINST HUMANITY!
By Keith Griffith For Dailymail.com
- Dr. Marion Gruber and her deputy Dr. Philip Krause will step down this fall
- Gruber leads the Office of Vaccines Research and Review at the FDA
- She played a key role in approving vaccines for protection against COVID-19
- But is reportedly frustrated at White House announcement of booster shots
- Biden administration wants to give boosters for all three vaccines in use in US
- But the FDA has yet to rule on booster doses for the general public
- Some see Biden’s move as politicized and premature before FDA approval
- There has also been tension between the FDA and the CDC vaccine panel
Two of the U.S. Food and Drug Administration’s top vaccine regulators plan to leave the agency in the next several months amid a reported power struggle with the White House and CDC over COVID-19 booster shots.
Dr. Marion Gruber, director of the FDA’s Office of Vaccines Research and Review, plans to step down on October 31 and her top deputy Dr. Philip Krause also plans to leave the FDA in November, according to a department memo.
Gruber played a key role in approving COVID-19 vaccines for the public, but her departure comes amid reports that FDA officials are frustrated with the White House for announcing booster shots before regulators formally approved them.
President Joe Biden has vowed to begin offering booster shots to the general public on September 20, a move that many health experts view as politicized and premature in coming before the FDA issues a formal recommendation.
In the US, the first courses of COVID vaccines from Johnson & Johnson and Moderna have emergency use authorization from the FDA, while the Pfizer vaccine’s two-dose initial course has full approval. But the FDA has yet to rule on widespread booster doses.